Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Change in Receivables: 2015-2024

Historic Change in Receivables for AC Immune (ACIU) over the last 10 years, with Dec 2024 value amounting to $16.9 million.

  • AC Immune's Change in Receivables fell 248.04% to -$526,281 in Q3 2025 from the same period last year, while for Sep 2025 it was $16.1 million, marking a year-over-year increase of 195.55%. This contributed to the annual value of $16.9 million for FY2024, which is 201.26% up from last year.
  • AC Immune's Change in Receivables amounted to $16.9 million in FY2024, which was up 201.26% from -$16.7 million recorded in FY2023.
  • AC Immune's Change in Receivables' 5-year high stood at $16.9 million during FY2024, with a 5-year trough of -$16.7 million in FY2023.
  • In the last 3 years, AC Immune's Change in Receivables had a median value of $37,369 in 2022 and averaged $82,349.
  • Its Change in Receivables has fluctuated over the past 5 years, first crashed by 44,749.16% in 2023, then soared by 201.26% in 2024.
  • Yearly analysis of 5 years shows AC Immune's Change in Receivables stood at -$27,654 in 2020, then slumped by 291.77% to -$108,340 in 2021, then soared by 134.49% to $37,369 in 2022, then tumbled by 44,749.16% to -$16.7 million in 2023, then surged by 201.26% to $16.9 million in 2024.